These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cannabinoids biology: the search for new therapeutic targets. Felder CC; Dickason-Chesterfield AK; Moore SA Mol Interv; 2006 Jun; 6(3):149-61. PubMed ID: 16809476 [TBL] [Abstract][Full Text] [Related]
23. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Golech SA; McCarron RM; Chen Y; Bembry J; Lenz F; Mechoulam R; Shohami E; Spatz M Brain Res Mol Brain Res; 2004 Dec; 132(1):87-92. PubMed ID: 15548432 [TBL] [Abstract][Full Text] [Related]
24. [Membrane cholesterol mediates the endocannabinoids-anandamide affection on HepG2 cells]. Wu WJ; Yang Q; Cao QF; Zhang YW; Xia YJ; Hu XW; Tang WX Zhonghua Gan Zang Bing Za Zhi; 2010 Mar; 18(3):204-8. PubMed ID: 20380798 [TBL] [Abstract][Full Text] [Related]
25. Activation of the cannabinoid receptor 2 increases renal perfusion. Pressly JD; Soni H; Jiang S; Wei J; Liu R; Moore BM; Adebiyi A; Park F Physiol Genomics; 2019 Mar; 51(3):90-96. PubMed ID: 30707046 [TBL] [Abstract][Full Text] [Related]
26. Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure. Weis F; Beiras-Fernandez A; Sodian R; Kaczmarek I; Reichart B; Beiras A; Schelling G; Kreth S J Mol Cell Cardiol; 2010 Jun; 48(6):1187-93. PubMed ID: 19931541 [TBL] [Abstract][Full Text] [Related]
27. The pharmacology of cannabinoid receptors and their ligands: an overview. Pertwee RG Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099 [TBL] [Abstract][Full Text] [Related]
28. The role of the pancreatic endocannabinoid system in glucose metabolism. Bermúdez-Silva FJ; Suárez Pérez J; Nadal A; Rodríguez de Fonseca F Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):87-102. PubMed ID: 19285263 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of fatty-acid amide hydrolase enhances cannabinoid stress-induced analgesia: sites of action in the dorsolateral periaqueductal gray and rostral ventromedial medulla. Suplita RL; Farthing JN; Gutierrez T; Hohmann AG Neuropharmacology; 2005 Dec; 49(8):1201-9. PubMed ID: 16129456 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of selective cannabinoid CB(1) and CB(2) receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis. Tambaro S; Casu MA; Mastinu A; Lazzari P Eur J Pharmacol; 2014 Apr; 729():67-74. PubMed ID: 24561047 [TBL] [Abstract][Full Text] [Related]
33. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630 [TBL] [Abstract][Full Text] [Related]
34. Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis. Pandey R; Hegde VL; Singh NP; Hofseth L; Singh U; Ray S; Nagarkatti M; Nagarkatti PS Vitam Horm; 2009; 81():487-504. PubMed ID: 19647124 [TBL] [Abstract][Full Text] [Related]
35. [Anandamide and R-(+)-methanandamide prevent development of ischemic and reperfusion arrhythmia in rats by stimulation of CB2-receptors]. Krylatov AV; Uzhachenko RV; Maslov LN; Ugdyzhekova DS; Bernatskaia NA; Pertwee R; Stefano GB; Makriyannis A Eksp Klin Farmakol; 2002; 65(3):6-9. PubMed ID: 12227101 [TBL] [Abstract][Full Text] [Related]
36. Control of pain initiation by endogenous cannabinoids. Calignano A; La Rana G; Giuffrida A; Piomelli D Nature; 1998 Jul; 394(6690):277-81. PubMed ID: 9685157 [TBL] [Abstract][Full Text] [Related]
37. Activation of cannabinoid CB1 receptors induces glucose intolerance in rats. Bermúdez-Siva FJ; Serrano A; Diaz-Molina FJ; Sánchez Vera I; Juan-Pico P; Nadal A; Fuentes E; Rodríguez de Fonseca F Eur J Pharmacol; 2006 Feb; 531(1-3):282-4. PubMed ID: 16423347 [TBL] [Abstract][Full Text] [Related]
38. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability. Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105 [TBL] [Abstract][Full Text] [Related]
39. Attenuation of allergic contact dermatitis through the endocannabinoid system. Karsak M; Gaffal E; Date R; Wang-Eckhardt L; Rehnelt J; Petrosino S; Starowicz K; Steuder R; Schlicker E; Cravatt B; Mechoulam R; Buettner R; Werner S; Di Marzo V; Tüting T; Zimmer A Science; 2007 Jun; 316(5830):1494-7. PubMed ID: 17556587 [TBL] [Abstract][Full Text] [Related]
40. Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington's disease. Dowie MJ; Bradshaw HB; Howard ML; Nicholson LF; Faull RL; Hannan AJ; Glass M Neuroscience; 2009 Sep; 163(1):456-65. PubMed ID: 19524019 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]